Dear Spiral User, we appreciate your patience during this upgrade which is to benefit our userbase, improve their experience in Spiral, introduce improvements, fixes and maintaining our versioning for future updates. Please note if you encounter any issues in Spiral, please raise a ticket to Research Applications team providing as much detail as possible in order to help us resolve your query. Again, we thank you for your patience and support during the upgrade. Kind Regards, Spiral Upgrade Team.
 
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies
File(s)
Author(s)
Calderon, MA
Demoly, P
Casale, T
Akdis, CA
Bachert, C
Type
Journal Article
Abstract
Allergic diseases often occur early in life and persist throughout life. This life-course perspective should be considered in allergen immunotherapy. In particular it is essential to understand whether this al treatment may be used in old age adults. The current paper was developed by a working group of AIRWAYS integrated care pathways for airways diseases, the model of chronic respiratory diseases of the European Innovation Partnership on active and healthy ageing (DG CONNECT and DG Santé). It considered (1) the political background, (2) the rationale for allergen immunotherapy across the life cycle, (3) the unmet needs for the treatment, in particular in preschool children and old age adults, (4) the strategic framework and the practical approach to synergize current initiatives in allergen immunotherapy, its mechanisms and the concept of active and healthy ageing.
Date Issued
2016-11-23
Date Acceptance
2016-11-02
Citation
Clinical and Translational Allergy, 2016, 6
URI
DOI
ISSN
2045-7022
Publisher
BioMed Central
Journal / Book Title
Clinical and Translational Allergy
Volume
6
Copyright Statement
© 2016 The Authors. Published by BioMed Central. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sponsor
Medical Research Council (MRC)
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000390120900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
MR/K002449/1
Subjects
Science & Technology
Life Sciences & Biomedicine
Allergy
Allergen immunotherapy
EIP on AHA
AIRWAYS ICPs
Rhinitis
Asthma
Ageing
GRASS-POLLEN ALLERGY
IMMUNOLOGY/PRACTALL CONSENSUS REPORT
EUROPEAN INNOVATION PARTNERSHIP
EAACI POSITION PAPER
SUBLINGUAL IMMUNOTHERAPY
INTERNATIONAL CONSENSUS
ORAL IMMUNOTHERAPY
PRECISION MEDICINE
NATIONAL DATABASES
RUSH IMMUNOTHERAPY
Publication Status
Published
Article Number
ARTN 41